PHARMAUST LIMITED - Announcements

Market Cap $94.80M Add to my watchlist

Healthcare

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

PAA	Resignation of Dr Michael Thurn & appointment of John Clark	PRICE SENSITIVE	23/04/24	209.88KB	Share
PAA	Cleansing Notice		19/04/24	154.47KB	Share
PAA	Application for quotation of securities - PAA		19/04/24	15.5KB	Share
PAA	PharmAust makes Head of Manufacturing appointment		18/04/24	234.19KB	Share
PAA	Final Ethics Approval for Open-Label MND Extension Study	PRICE SENSITIVE	10/04/24	242.16KB	Share
PAA	Cleansing Notice		05/04/24	154.35KB	Share
PAA	Application for quotation of securities - PAA		05/04/24	15.49KB	Share
PAA	Media clarification	PRICE SENSITIVE	02/04/24	182.78KB	Share
PAA	Trading Halt	PRICE SENSITIVE	02/04/24	192.63KB	Share
PAA	Pause in Trading	PRICE SENSITIVE	02/04/24	115.56KB	Share
PAA	Cleansing Notice		27/03/24	154.78KB	Share
PAA	Application for quotation of securities - PAA		27/03/24	18.59KB	Share
PAA	PharmAust to present at NWR Virtual Healthcare Conference		19/03/24	185.71KB	Share
PAA	Singapore Healthcare Day Presentation		14/03/24	3.61MB	Share
PAA	Positive clinical data filed with FDA to support ODD request	PRICE SENSITIVE	14/03/24	195.8KB	Share
PAA	Cleansing Notice		07/03/24	154.33KB	Share
PAA	Application for quotation of securities - PAA		07/03/24	15.49KB	Share
PAA	Appendix 4D & Half-Year Report	PRICE SENSITIVE	29/02/24	637.51KB	Share
PAA	Cleansing Notice		28/02/24	154.34KB	Share
PAA	Application for quotation of securities - PAA		28/02/24	17.94KB	Share
PAA	Presentation - Phase 1 Top-Line Results	PRICE SENSITIVE	27/02/24	1.11MB	Share
PAA	Positive Phase 1 MEND Study Top-Line Results	PRICE SENSITIVE	27/02/24	265.55KB	Share
PAA	Investor webinar - Phase 1 MND Study Top-Line Results		26/02/24	182.32KB	Share
PAA	Trading Halt	PRICE SENSITIVE	26/02/24	555.56KB	Share
PAA	Cleansing Notice		23/02/24	230.12KB	Share
PAA	Change of Director's Interest Notice		23/02/24	183.97KB	Share
PAA	Notification regarding unquoted securities - PAA		23/02/24	16.02KB	Share
PAA	Application for quotation of securities - PAA		23/02/24	16.43KB	Share
PAA	Application for quotation of securities - PAA		23/02/24	17.82KB	Share
PAA	PharmAust Forms World-Class Scientific Advisory Board	PRICE SENSITIVE	22/02/24	196.22KB	Share
PAA	Results of General Meeting		22/02/24	443.5KB	Share
PAA	EGM Shareholder Presentation		21/02/24	3.24MB	Share
PAA	FDA Outlines Pathway to Accelerated Approval for MPL in MND	PRICE SENSITIVE	16/02/24	155.77KB	Share
PAA	Extension Study Begins, Analysis Suggests Survival Benefit	PRICE SENSITIVE	14/02/24	349.96KB	Share
PAA	Cleansing Notice		13/02/24	211.81KB	Share
PAA	Application for quotation of securities - PAA		13/02/24	16.25KB	Share
PAA	Cleansing Notice		06/02/24	211.66KB	Share
PAA	Application for quotation of securities - PAA		06/02/24	15.48KB	Share
PAA	Investor Presentation and Non-Deal Roadshow		05/02/24	2.64MB	Share
PAA	Initial Director's Interest Notice		05/02/24	134.26KB	Share
PAA	Dr Thomas Duthy appointed as Non-Executive Director		05/02/24	152KB	Share
PAA	Appendix 4C & Quarterly Update	PRICE SENSITIVE	31/01/24	298.03KB	Share
PAA	Ethics Committee Approval for Open-Label MND Extension Study	PRICE SENSITIVE	30/01/24	189.05KB	Share
PAA	FDA Provides Clear Feedback for ODD Approval	PRICE SENSITIVE	29/01/24	155.4KB	Share
PAA	Notice of General Meeting & Proxy Form		19/01/24	527.39KB	Share
PAA	Notification regarding unquoted securities - PAA		19/01/24	30.82KB	Share
PAA	PharmAust Partners with Berry Consultants for MND Phase 2/3	PRICE SENSITIVE	16/01/24	158.48KB	Share
PAA	Appendix 3Y x 3		05/01/24	229.44KB	Share
PAA	Cleansing Notice		05/01/24	211.66KB	Share
PAA	Application for quotation of securities - PAA		05/01/24	25.4KB	Share
PAA	FDA Grants PharmAust Pre-IND Meeting	PRICE SENSITIVE	02/01/24	156.3KB	Share
PAA	Application for quotation of securities - PAA		02/01/24	25.35KB	Share
PAA	Cleansing Notice		02/01/24	211.67KB	Share
PAA	Notification regarding unquoted securities - PAA		02/01/24	27.45KB	Share
PAA	Application for quotation of securities - PAA		02/01/24	27.19KB	Share
PAA	Proposed issue of securities - PAA		02/01/24	26.96KB	Share
PAA	Cleansing Prospectus & Target Market Determination		02/01/24	401.66KB	Share
PAA	Cleansing Notice		22/12/23	212.01KB	Share
PAA	Application for quotation of securities - PAA		22/12/23	27.08KB	Share
PAA	FightMND Invites PharmAust to Apply for Phase 2/3 Funding	PRICE SENSITIVE	22/12/23	154.99KB	Share
PAA	Application for quotation of securities - PAA		21/12/23	25.52KB	Share
PAA	Application for quotation of securities - PAA		21/12/23	24.87KB	Share
PAA	PharmAust Receives R&D Tax Incentive Refund	PRICE SENSITIVE	20/12/23	152.85KB	Share
PAA	PAAOA Top 20 & Distribution Report		19/12/23	104.26KB	Share
PAA	Appendix 3Y x 4		18/12/23	347.68KB	Share
PAA	Appendix 2A		18/12/23	373.9KB	Share
PAA	PharmAust Launches Interactive Investor Hub		18/12/23	138.79KB	Share
PAA	Cleansing Notice		18/12/23	211.49KB	Share
PAA	Application for quotation of securities - PAA		18/12/23	27KB	Share
PAA	Update - Proposed issue of securities - PAA		18/12/23	30.2KB	Share
PAA	93% take up in Options Offer	PRICE SENSITIVE	15/12/23	154.54KB	Share
PAA	Update - Proposed issue of securities - PAA		14/12/23	27.31KB	Share
PAA	Proposed issue of securities - PAA		13/12/23	30.15KB	Share
PAA	PharmAust Raises $3.5 Million at a Premium	PRICE SENSITIVE	13/12/23	170.98KB	Share
PAA	Trading Halt	PRICE SENSITIVE	11/12/23	549.26KB	Share
PAA	New Hires & Attendance at International MND Symposium		06/12/23	206.87KB	Share
PAA	PAA completes Phase 1 and files for Orphan Drug Designation	PRICE SENSITIVE	01/12/23	184.1KB	Share
PAA	Prospectus & Target Market Determination	PRICE SENSITIVE	21/11/23	423KB	Share
PAA	Results of Annual General Meeting		20/11/23	271.15KB	Share
PAA	Appendix 3Y x 4		06/11/23	258.57KB	Share
PAA	PharmAust to present at Emerging ASX Gems Conference		02/11/23	178.51KB	Share
PAA	Appendix 4C and Quarterly Update	PRICE SENSITIVE	30/10/23	3.11MB	Share
PAA	Application for quotation of securities - PAA		27/10/23	24.8KB	Share
PAA	Notice of Annual General Meeting & Proxy Form		19/10/23	541.63KB	Share
PAA	Proposed issue of securities - PAA		18/10/23	27.42KB	Share
PAA	Options Offer to Existing Listed Option Holders	PRICE SENSITIVE	18/10/23	331.86KB	Share
PAA	Final MND Patient in Cohort 4 Successfully Completes Dosing	PRICE SENSITIVE	13/10/23	226.42KB	Share
PAA	Canine Oncology Data Supports Progression to Registration	PRICE SENSITIVE	09/10/23	1.18MB	Share
PAA	Trading Halt	PRICE SENSITIVE	06/10/23	524.8KB	Share
PAA	Clarification to notification of expiry of quoted options		02/10/23	152.72KB	Share
PAA	Notification of expiry of quoted options		29/09/23	160.72KB	Share
PAA	Change of registry address notification		15/09/23	152.87KB	Share
PAA	Notification regarding unquoted securities - PAA		08/09/23	31.85KB	Share
PAA	Cleansing Notice		04/09/23	211.39KB	Share
PAA	Application for quotation of securities - PAA		04/09/23	24.48KB	Share
PAA	Appendix 4G & Corporate Governance Statement		31/08/23	588.23KB	Share
PAA	Appendix 4E & Full Year Statutory Accounts	PRICE SENSITIVE	31/08/23	1.21MB	Share
PAA	Chief Executive Officer Appointment	PRICE SENSITIVE	28/08/23	209.6KB	Share
PAA	Release of Restricted Securities from Escrow		25/08/23	183.72KB	Share
PAA	Additional Phase 1 data suggest MPL may inhibit MND	PRICE SENSITIVE	22/08/23	351.67KB	Share

PAA Resignation of Dr Michael Thurn & appointment of John Clark
23/04/24	PRICE SENSITIVE	209.88KB	Share
PAA Cleansing Notice
19/04/24		154.47KB	Share
PAA Application for quotation of securities - PAA
19/04/24		15.5KB	Share
PAA PharmAust makes Head of Manufacturing appointment
18/04/24		234.19KB	Share
PAA Final Ethics Approval for Open-Label MND Extension Study
10/04/24	PRICE SENSITIVE	242.16KB	Share
PAA Cleansing Notice
05/04/24		154.35KB	Share
PAA Application for quotation of securities - PAA
05/04/24		15.49KB	Share
PAA Media clarification
02/04/24	PRICE SENSITIVE	182.78KB	Share
PAA Trading Halt
02/04/24	PRICE SENSITIVE	192.63KB	Share
PAA Pause in Trading
02/04/24	PRICE SENSITIVE	115.56KB	Share
PAA Cleansing Notice
27/03/24		154.78KB	Share
PAA Application for quotation of securities - PAA
27/03/24		18.59KB	Share
PAA PharmAust to present at NWR Virtual Healthcare Conference
19/03/24		185.71KB	Share
PAA Singapore Healthcare Day Presentation
14/03/24		3.61MB	Share
PAA Positive clinical data filed with FDA to support ODD request
14/03/24	PRICE SENSITIVE	195.8KB	Share
PAA Cleansing Notice
07/03/24		154.33KB	Share
PAA Application for quotation of securities - PAA
07/03/24		15.49KB	Share
PAA Appendix 4D & Half-Year Report
29/02/24	PRICE SENSITIVE	637.51KB	Share
PAA Cleansing Notice
28/02/24		154.34KB	Share
PAA Application for quotation of securities - PAA
28/02/24		17.94KB	Share
PAA Presentation - Phase 1 Top-Line Results
27/02/24	PRICE SENSITIVE	1.11MB	Share
PAA Positive Phase 1 MEND Study Top-Line Results
27/02/24	PRICE SENSITIVE	265.55KB	Share
PAA Investor webinar - Phase 1 MND Study Top-Line Results
26/02/24		182.32KB	Share
PAA Trading Halt
26/02/24	PRICE SENSITIVE	555.56KB	Share
PAA Cleansing Notice
23/02/24		230.12KB	Share
PAA Change of Director's Interest Notice
23/02/24		183.97KB	Share
PAA Notification regarding unquoted securities - PAA
23/02/24		16.02KB	Share
PAA Application for quotation of securities - PAA
23/02/24		16.43KB	Share
PAA Application for quotation of securities - PAA
23/02/24		17.82KB	Share
PAA PharmAust Forms World-Class Scientific Advisory Board
22/02/24	PRICE SENSITIVE	196.22KB	Share
PAA Results of General Meeting
22/02/24		443.5KB	Share
PAA EGM Shareholder Presentation
21/02/24		3.24MB	Share
PAA FDA Outlines Pathway to Accelerated Approval for MPL in MND
16/02/24	PRICE SENSITIVE	155.77KB	Share
PAA Extension Study Begins, Analysis Suggests Survival Benefit
14/02/24	PRICE SENSITIVE	349.96KB	Share
PAA Cleansing Notice
13/02/24		211.81KB	Share
PAA Application for quotation of securities - PAA
13/02/24		16.25KB	Share
PAA Cleansing Notice
06/02/24		211.66KB	Share
PAA Application for quotation of securities - PAA
06/02/24		15.48KB	Share
PAA Investor Presentation and Non-Deal Roadshow
05/02/24		2.64MB	Share
PAA Initial Director's Interest Notice
05/02/24		134.26KB	Share
PAA Dr Thomas Duthy appointed as Non-Executive Director
05/02/24		152KB	Share
PAA Appendix 4C & Quarterly Update
31/01/24	PRICE SENSITIVE	298.03KB	Share
PAA Ethics Committee Approval for Open-Label MND Extension Study
30/01/24	PRICE SENSITIVE	189.05KB	Share
PAA FDA Provides Clear Feedback for ODD Approval
29/01/24	PRICE SENSITIVE	155.4KB	Share
PAA Notice of General Meeting & Proxy Form
19/01/24		527.39KB	Share
PAA Notification regarding unquoted securities - PAA
19/01/24		30.82KB	Share
PAA PharmAust Partners with Berry Consultants for MND Phase 2/3
16/01/24	PRICE SENSITIVE	158.48KB	Share
PAA Appendix 3Y x 3
05/01/24		229.44KB	Share
PAA Cleansing Notice
05/01/24		211.66KB	Share
PAA Application for quotation of securities - PAA
05/01/24		25.4KB	Share
PAA FDA Grants PharmAust Pre-IND Meeting
02/01/24	PRICE SENSITIVE	156.3KB	Share
PAA Application for quotation of securities - PAA
02/01/24		25.35KB	Share
PAA Cleansing Notice
02/01/24		211.67KB	Share
PAA Notification regarding unquoted securities - PAA
02/01/24		27.45KB	Share
PAA Application for quotation of securities - PAA
02/01/24		27.19KB	Share
PAA Proposed issue of securities - PAA
02/01/24		26.96KB	Share
PAA Cleansing Prospectus & Target Market Determination
02/01/24		401.66KB	Share
PAA Cleansing Notice
22/12/23		212.01KB	Share
PAA Application for quotation of securities - PAA
22/12/23		27.08KB	Share
PAA FightMND Invites PharmAust to Apply for Phase 2/3 Funding
22/12/23	PRICE SENSITIVE	154.99KB	Share
PAA Application for quotation of securities - PAA
21/12/23		25.52KB	Share
PAA Application for quotation of securities - PAA
21/12/23		24.87KB	Share
PAA PharmAust Receives R&D Tax Incentive Refund
20/12/23	PRICE SENSITIVE	152.85KB	Share
PAA PAAOA Top 20 & Distribution Report
19/12/23		104.26KB	Share
PAA Appendix 3Y x 4
18/12/23		347.68KB	Share
PAA Appendix 2A
18/12/23		373.9KB	Share
PAA PharmAust Launches Interactive Investor Hub
18/12/23		138.79KB	Share
PAA Cleansing Notice
18/12/23		211.49KB	Share
PAA Application for quotation of securities - PAA
18/12/23		27KB	Share
PAA Update - Proposed issue of securities - PAA
18/12/23		30.2KB	Share
PAA 93% take up in Options Offer
15/12/23	PRICE SENSITIVE	154.54KB	Share
PAA Update - Proposed issue of securities - PAA
14/12/23		27.31KB	Share
PAA Proposed issue of securities - PAA
13/12/23		30.15KB	Share
PAA PharmAust Raises $3.5 Million at a Premium
13/12/23	PRICE SENSITIVE	170.98KB	Share
PAA Trading Halt
11/12/23	PRICE SENSITIVE	549.26KB	Share
PAA New Hires & Attendance at International MND Symposium
06/12/23		206.87KB	Share
PAA PAA completes Phase 1 and files for Orphan Drug Designation
01/12/23	PRICE SENSITIVE	184.1KB	Share
PAA Prospectus & Target Market Determination
21/11/23	PRICE SENSITIVE	423KB	Share
PAA Results of Annual General Meeting
20/11/23		271.15KB	Share
PAA Appendix 3Y x 4
06/11/23		258.57KB	Share
PAA PharmAust to present at Emerging ASX Gems Conference
02/11/23		178.51KB	Share
PAA Appendix 4C and Quarterly Update
30/10/23	PRICE SENSITIVE	3.11MB	Share
PAA Application for quotation of securities - PAA
27/10/23		24.8KB	Share
PAA Notice of Annual General Meeting & Proxy Form
19/10/23		541.63KB	Share
PAA Proposed issue of securities - PAA
18/10/23		27.42KB	Share
PAA Options Offer to Existing Listed Option Holders
18/10/23	PRICE SENSITIVE	331.86KB	Share
PAA Final MND Patient in Cohort 4 Successfully Completes Dosing
13/10/23	PRICE SENSITIVE	226.42KB	Share
PAA Canine Oncology Data Supports Progression to Registration
09/10/23	PRICE SENSITIVE	1.18MB	Share
PAA Trading Halt
06/10/23	PRICE SENSITIVE	524.8KB	Share
PAA Clarification to notification of expiry of quoted options
02/10/23		152.72KB	Share
PAA Notification of expiry of quoted options
29/09/23		160.72KB	Share
PAA Change of registry address notification
15/09/23		152.87KB	Share
PAA Notification regarding unquoted securities - PAA
08/09/23		31.85KB	Share
PAA Cleansing Notice
04/09/23		211.39KB	Share
PAA Application for quotation of securities - PAA
04/09/23		24.48KB	Share
PAA Appendix 4G & Corporate Governance Statement
31/08/23		588.23KB	Share
PAA Appendix 4E & Full Year Statutory Accounts
31/08/23	PRICE SENSITIVE	1.21MB	Share
PAA Chief Executive Officer Appointment
28/08/23	PRICE SENSITIVE	209.6KB	Share
PAA Release of Restricted Securities from Escrow
25/08/23		183.72KB	Share
PAA Additional Phase 1 data suggest MPL may inhibit MND
22/08/23	PRICE SENSITIVE	351.67KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 24.0¢		Change -0.010(4.00%)		Mkt cap ! $94.80M

Open	High	Low	Value	Volume
25.0¢	25.0¢	23.5¢	$140.9K	586.1K

Buyers (Bids)

No.	Vol.	Price($)
2	12010	24.0¢

Sellers (Offers)

Price($)	Vol.	No.
24.5¢	70000	1

View Market Depth

No.	Vol.	Price($)
2	12010	0.240
2	30525	0.235
10	116000	0.230
5	192316	0.225
6	236160	0.220

Price($)	Vol.	No.
0.245	70000	1
0.250	15000	1
0.255	85000	3
0.260	111500	3
0.265	134833	4

Last trade - 16.10pm 26/04/2024 (20 minute delay)


Last 23.5¢		Change -0.010 ( 4.08 %)
Open	High	Low	Volume
24.0¢	24.5¢	23.5¢	164909
Last updated 15.58pm 26/04/2024 ?

PAA (ASX) Chart

PHARMAUST LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories